Risk for late-onset Alzheimer’s disease (LOAD), the most prevalent dementia, is partially
driven by genetics. To identify LOAD risk loci, we performed a large genome-wide association …

Recent findings of a linkage between high blood pressure (BP) and later development of
dementia have given new prospects on cerebral target-organ damage in hypertension and …

Background The cholinesterase inhibitor donepezil is used to treat mild-to-moderate
Alzheimer's disease. Its efficacy in severe dementia has not been assessed and is controversial. …

Background and Purpose—Cerebrovascular disease is increasingly recognized as a cause
of dementia and cognitive decline. We have previously reported an association between …

Background Alzheimer's disease (AD), the most common cause of dementia, is a major cause
of disability and care burden in the elderly. This study aims to estimate the costs of formal …

Objectives: We hypothesized that CSF neurofilament light (NFL) levels would be elevated in
dementias with subcortical involvement, including vascular dementia (VaD), but less …

Importance One characteristic histopathological event in Alzheimer disease (AD) is cerebral
amyloid aggregation, which can be detected by biomarkers in cerebrospinal fluid (CSF) and …

Background There is a well-established inverse relation between education and mortality
from cardiovascular disease and cancer. The reasons for this are still in part unclear. We …

Progressive cognitive decline in combination with a cerebrospinal fluid biomarker pattern of
low levels of amyloid-β 1-42 and high levels of total tau and phosphorylated tau is typical of …

Aims: Our aim was to evaluate the longitudinal associations of individual and multiple vascular
risk factors with the subsequent development of dementia and Alzheimer’s disease (AD). …